Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt
BMC Infectious Diseases, Volume 2, Article 29, Year 2002
Notification
URL copied to clipboard!
Description
Background: Hepatitis C virus (HCV) infection and schistosomiasis are major public health problems in the Nile Delta of Egypt. To control schistosomiasis, mass treatment campaigns using tartar emetic injections were conducted in the 1960s through 1980s. Evidence suggests that inadequately sterilized needles used in these campaigns contributed to the transmission of HCV in the region. To corroborate this evidence, this study evaluates whether HCV infections clustered within houses in which household members had received parenteral treatment for schistosomiasis. Methods: A serosurvey was conducted in a village in the Nile Delta and residents were questioned about prior treatment for schistosomiasis. Sera were evaluated for the presence of antibodies to HCV. The GEE2 approach was used to test for clustering of HCV infections, where correlation of HCV infections within household members who had been treated for schistosomiasis was the parameter of interest. Results: A history of parenteral treatment for schistosomiasis was observed to cluster within households, OR for clustering: 2.44 (95% CI: 1.47-4.06). Overall, HCV seropositivity was 40% (321/796) and was observed to cluster within households that had members who had received parenteral treatment for schistosomiasis, OR for clustering: 1.76 (95% CI: 1.05-2.95). No such evidence for clustering was found in the remaining households. Conclusion: Clustering of HCV infections and receipt of parenteral treatment for schistosomiasis within the same households provides further evidence of an association between the schistosomiasis treatment campaigns and the high HCV seroprevalence rates currently observed in the Nile delta of Egypt. © 2002 Rao et al; licensee BioMed Central Ltd.
Authors & Co-Authors
Rao, Malla Raghava
United States, Bethesda
National Institute of Child Health and Human Development Nichd
Naficy, Abdollah B.
United States, Bethesda
National Institute of Child Health and Human Development Nichd
Darwish, Medhat Abdel Fattah
Egypt, Cairo
Faculty of Medicine - Ain Shams University
Darwish, Nebal M.
Egypt, Cairo
Faculty of Medicine - Ain Shams University
Schisterman, Enrique F.
United States, Bethesda
National Institute of Child Health and Human Development Nichd
Clemens, John David
United States, Bethesda
National Institute of Child Health and Human Development Nichd
Edelman, Robert
United States, Baltimore
University of Maryland, Baltimore Umb
Statistics
Citations: 102
Authors: 7
Affiliations: 3
Identifiers
Doi:
10.1186/1471-2334-2-29
ISSN:
14712334
Research Areas
Infectious Diseases
Study Locations
Egypt